NCT02659891View on ClinicalTrials.gov

IVIg to Treat BK Viremia in Kidney Transplant Recipients

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 10, 2020

Study Completion Date

March 31, 2021

Conditions
Kidney TransplantationBK VirusIsoantibodies
Interventions
BIOLOGICAL

IVIg

OTHER

Placebo

Trial Locations (2)

02114

Beth Israel Deaconess Medical Center, Boston

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02659891 - IVIg to Treat BK Viremia in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter